Global Blood Culture Test
Global Blood Culture Test

Blood Culture Test Comprehensive Study by Type (Consumables (Bacterial Infections, Fungal Infections, Mycobacterial Infections, Blood Culture Media, Assay, Kits, and Reagents, Blood Culture Accessories), Instruments (Bacterial Infections, Fungal Infections, Mycobacterial Infections, Laboratory Equipment, Automated Blood Culture Systems), Software & Services (Bacterial Infections, Fungal Infections, Mycobacterial Infections)), Application (Bacterial Infections, Fungal Infections, Mycobacterial Infections), Technology (Culture-based Technology, Molecular Technology (PCR, Microarray, PNA-FISH), Proteomic Technology), Technique (Conventional, Automated), End User (Hospitals Laboratories, Reference Laboratories, Others) Players and Region - Global Market Outlook to 2024

Blood Culture Test Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024 | CAGR: 9.1%  

May 2019 Edition 228 Pages 176 Tables & Figures
Sample Report Speak with Analyst Request Discount
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Blood Culture Test Market Overview:
The growing number of sepsis cases and high cost of treatment and rising geriatric population will boost global blood culture test market. Blood culture tests are done to identify the existence of microorganisms including bacteria or fungi in the blood. It is generally used to determine the occurrence of infection, identify the contributing agents and to guide the proper treatment necessary to a patient. Additionally, it is used to recognize a blood infection which if otherwise left unnoticed can lead to a serious and fatal condition called sepsis. Some of the key players profiled in the study are Becton, Dickinson and Company (United States), bioMérieux SA (France), Thermo Fisher Scientific, Inc. (United States), Cepheid, Inc. (United States), Abbott Laboratories (United States), Nanosphere, Inc. (United States), Roche Diagnostics (Switzerland), Beckman Coulter (United States), Bruker Corporation (United States) and IRIDICA (United States). According to Market Analyst at AMA, the Global Blood Culture Test market may see a growth rate of 9.1%

On the basis of geography, the market of Blood Culture Test has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2018. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. If we see Market by Technology , the sub-segment i.e. Culture-based Technology will boost the Blood Culture Test market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Technique, the sub-segment i.e. Conventional will boost the Blood Culture Test market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals Laboratories will boost the Blood Culture Test market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • High Occurrence of Bloodstream Infections
  • High Prevalence of Infectious Diseases

Market Trend
  • Growing Number of Regulatory Approvals & New Product Launches
  • High Adoption due to Rising Demand for Rapid Diagnostic Techniques

Restraints
  • Rising Concern about the High Cost of Automated Instruments
  • Dearth of Skilled Laboratory Technicians

Opportunities
  • Identification of Antibiotic-Resistant Microorganisms
  • Huge Opportunity in Emerging Economies

Challenges
  • Survival of Players Offering Conventional Blood Culture Products
  • Intense Competition among the Players


On 8th April 2019, BD (Becton, Dickinson and Company), a leading global medical technology company has announced global availability of BD BACTEC™; platelet quality control media, which allows microbiology laboratories, blood banks and transfusion services to identify contaminated platelet units.


The global blood culture tests market is highly competitive due to the presence of key market players. To surge the adoption of automated blood culture tests, many key players are establishing or strengthening their research associations to improve safe and efficient products. Additionally, new market players have to develop efficient as well as cost-effective blood culture tests to compete against existing and upcoming market entrants and rise the approval of their products.

Target Audience:
Molecular Diagnostic Companies, Manufacturers of Clinical Microbiology Instruments and Consumables, Venture Capitalists, Research and Consulting Firms, Clinical Diagnostic Laboratories, Government Bodies, Government and Private Research Center and Others

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Blood Culture Test market on the basis of product [Consumables [Bacterial Infections, Fungal Infections, Mycobacterial Infections, Blood Culture Media, Assay, Kits, and Reagents, Blood Culture Accessories], Instruments [Bacterial Infections, Fungal Infections, Mycobacterial Infections, Laboratory Equipment, Automated Blood Culture Systems] and Software & Services [Bacterial Infections, Fungal Infections, Mycobacterial Infections]] , application [Bacterial Infections, Fungal Infections and Mycobacterial Infections], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Blood Culture Test market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Blood Culture Test industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are T2 Biosystems (United States), Danaher Corporation (United States) and Luminex Corporation (United States).
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Blood Culture Test market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.
Report Objectives / Segmentation Covered
By Type
  • Consumables [Bacterial Infections, Fungal Infections, Mycobacterial Infections, Blood Culture Media, Assay, Kits, and Reagents, Blood Culture Accessories]
  • Instruments [Bacterial Infections, Fungal Infections, Mycobacterial Infections, Laboratory Equipment, Automated Blood Culture Systems]
  • Software & Services [Bacterial Infections, Fungal Infections, Mycobacterial Infections]
By Application
  • Bacterial Infections
  • Fungal Infections
  • Mycobacterial Infections
By Technology
  • Culture-based Technology
  • Molecular Technology [PCR, Microarray, PNA-FISH]
  • Proteomic Technology

By Technique
  • Conventional
  • Automated

By End User
  • Hospitals Laboratories
  • Reference Laboratories
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Occurrence of Bloodstream Infections
      • 3.2.2. High Prevalence of Infectious Diseases
    • 3.3. Market Challenges
      • 3.3.1. Survival of Players Offering Conventional Blood Culture Products
      • 3.3.2. Intense Competition among the Players
    • 3.4. Market Trends
      • 3.4.1. Growing Number of Regulatory Approvals & New Product Launches
      • 3.4.2. High Adoption due to Rising Demand for Rapid Diagnostic Techniques
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Blood Culture Test, by Type, Application, Technology , Technique, End User and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Blood Culture Test (Value)
      • 5.2.1. Global Blood Culture Test by: Type (Value)
        • 5.2.1.1. Consumables [Bacterial Infections, Fungal Infections, Mycobacterial Infections, Blood Culture Media, Assay, Kits, and Reagents, Blood Culture Accessories]
        • 5.2.1.2. Instruments [Bacterial Infections, Fungal Infections, Mycobacterial Infections, Laboratory Equipment, Automated Blood Culture Systems]
        • 5.2.1.3. Software & Services [Bacterial Infections, Fungal Infections, Mycobacterial Infections]
      • 5.2.2. Global Blood Culture Test by: Application (Value)
        • 5.2.2.1. Bacterial Infections
        • 5.2.2.2. Fungal Infections
        • 5.2.2.3. Mycobacterial Infections
      • 5.2.3. Global Blood Culture Test by: Technique (Value)
        • 5.2.3.1. Conventional
        • 5.2.3.2. Automated
      • 5.2.4. Global Blood Culture Test by: End User (Value)
        • 5.2.4.1. Hospitals Laboratories
        • 5.2.4.2. Reference Laboratories
        • 5.2.4.3. Others
      • 5.2.5. Global Blood Culture Test Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Blood Culture Test: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Becton, Dickinson and Company (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. BioMérieux SA (France)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Thermo Fisher Scientific, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cepheid, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Abbott Laboratories (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Nanosphere, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Roche Diagnostics (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Beckman Coulter (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Bruker Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. IRIDICA (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Blood Culture Test Sale, by Type, Application, Technology , Technique, End User and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Blood Culture Test (Value)
      • 7.2.1. Global Blood Culture Test by: Type (Value)
        • 7.2.1.1. Consumables [Bacterial Infections, Fungal Infections, Mycobacterial Infections, Blood Culture Media, Assay, Kits, and Reagents, Blood Culture Accessories]
        • 7.2.1.2. Instruments [Bacterial Infections, Fungal Infections, Mycobacterial Infections, Laboratory Equipment, Automated Blood Culture Systems]
        • 7.2.1.3. Software & Services [Bacterial Infections, Fungal Infections, Mycobacterial Infections]
      • 7.2.2. Global Blood Culture Test by: Application (Value)
        • 7.2.2.1. Bacterial Infections
        • 7.2.2.2. Fungal Infections
        • 7.2.2.3. Mycobacterial Infections
      • 7.2.3. Global Blood Culture Test by: Technique (Value)
        • 7.2.3.1. Conventional
        • 7.2.3.2. Automated
      • 7.2.4. Global Blood Culture Test by: End User (Value)
        • 7.2.4.1. Hospitals Laboratories
        • 7.2.4.2. Reference Laboratories
        • 7.2.4.3. Others
      • 7.2.5. Global Blood Culture Test Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Blood Culture Test: by Type(USD Million)
  • Table 2. Blood Culture Test Consumables [Bacterial Infections, Fungal Infections, Mycobacterial Infections, Blood Culture Media, Assay, Kits, and Reagents, Blood Culture Accessories] , by Region USD Million (2013-2018)
  • Table 3. Blood Culture Test Instruments [Bacterial Infections, Fungal Infections, Mycobacterial Infections, Laboratory Equipment, Automated Blood Culture Systems] , by Region USD Million (2013-2018)
  • Table 4. Blood Culture Test Software & Services [Bacterial Infections, Fungal Infections, Mycobacterial Infections] , by Region USD Million (2013-2018)
  • Table 5. Blood Culture Test: by Application(USD Million)
  • Table 6. Blood Culture Test Bacterial Infections , by Region USD Million (2013-2018)
  • Table 7. Blood Culture Test Fungal Infections , by Region USD Million (2013-2018)
  • Table 8. Blood Culture Test Mycobacterial Infections , by Region USD Million (2013-2018)
  • Table 9. Blood Culture Test: by Technique(USD Million)
  • Table 10. Blood Culture Test Conventional , by Region USD Million (2013-2018)
  • Table 11. Blood Culture Test Automated , by Region USD Million (2013-2018)
  • Table 12. Blood Culture Test: by End User(USD Million)
  • Table 13. Blood Culture Test Hospitals Laboratories , by Region USD Million (2013-2018)
  • Table 14. Blood Culture Test Reference Laboratories , by Region USD Million (2013-2018)
  • Table 15. Blood Culture Test Others , by Region USD Million (2013-2018)
  • Table 16. South America Blood Culture Test, by Country USD Million (2013-2018)
  • Table 17. South America Blood Culture Test, by Type USD Million (2013-2018)
  • Table 18. South America Blood Culture Test, by Application USD Million (2013-2018)
  • Table 19. South America Blood Culture Test, by Technology USD Million (2013-2018)
  • Table 20. South America Blood Culture Test, by Technique USD Million (2013-2018)
  • Table 21. South America Blood Culture Test, by End User USD Million (2013-2018)
  • Table 22. Brazil Blood Culture Test, by Type USD Million (2013-2018)
  • Table 23. Brazil Blood Culture Test, by Application USD Million (2013-2018)
  • Table 24. Brazil Blood Culture Test, by Technology USD Million (2013-2018)
  • Table 25. Brazil Blood Culture Test, by Technique USD Million (2013-2018)
  • Table 26. Brazil Blood Culture Test, by End User USD Million (2013-2018)
  • Table 27. Argentina Blood Culture Test, by Type USD Million (2013-2018)
  • Table 28. Argentina Blood Culture Test, by Application USD Million (2013-2018)
  • Table 29. Argentina Blood Culture Test, by Technology USD Million (2013-2018)
  • Table 30. Argentina Blood Culture Test, by Technique USD Million (2013-2018)
  • Table 31. Argentina Blood Culture Test, by End User USD Million (2013-2018)
  • Table 32. Rest of South America Blood Culture Test, by Type USD Million (2013-2018)
  • Table 33. Rest of South America Blood Culture Test, by Application USD Million (2013-2018)
  • Table 34. Rest of South America Blood Culture Test, by Technology USD Million (2013-2018)
  • Table 35. Rest of South America Blood Culture Test, by Technique USD Million (2013-2018)
  • Table 36. Rest of South America Blood Culture Test, by End User USD Million (2013-2018)
  • Table 37. Asia Pacific Blood Culture Test, by Country USD Million (2013-2018)
  • Table 38. Asia Pacific Blood Culture Test, by Type USD Million (2013-2018)
  • Table 39. Asia Pacific Blood Culture Test, by Application USD Million (2013-2018)
  • Table 40. Asia Pacific Blood Culture Test, by Technology USD Million (2013-2018)
  • Table 41. Asia Pacific Blood Culture Test, by Technique USD Million (2013-2018)
  • Table 42. Asia Pacific Blood Culture Test, by End User USD Million (2013-2018)
  • Table 43. China Blood Culture Test, by Type USD Million (2013-2018)
  • Table 44. China Blood Culture Test, by Application USD Million (2013-2018)
  • Table 45. China Blood Culture Test, by Technology USD Million (2013-2018)
  • Table 46. China Blood Culture Test, by Technique USD Million (2013-2018)
  • Table 47. China Blood Culture Test, by End User USD Million (2013-2018)
  • Table 48. Japan Blood Culture Test, by Type USD Million (2013-2018)
  • Table 49. Japan Blood Culture Test, by Application USD Million (2013-2018)
  • Table 50. Japan Blood Culture Test, by Technology USD Million (2013-2018)
  • Table 51. Japan Blood Culture Test, by Technique USD Million (2013-2018)
  • Table 52. Japan Blood Culture Test, by End User USD Million (2013-2018)
  • Table 53. India Blood Culture Test, by Type USD Million (2013-2018)
  • Table 54. India Blood Culture Test, by Application USD Million (2013-2018)
  • Table 55. India Blood Culture Test, by Technology USD Million (2013-2018)
  • Table 56. India Blood Culture Test, by Technique USD Million (2013-2018)
  • Table 57. India Blood Culture Test, by End User USD Million (2013-2018)
  • Table 58. South Korea Blood Culture Test, by Type USD Million (2013-2018)
  • Table 59. South Korea Blood Culture Test, by Application USD Million (2013-2018)
  • Table 60. South Korea Blood Culture Test, by Technology USD Million (2013-2018)
  • Table 61. South Korea Blood Culture Test, by Technique USD Million (2013-2018)
  • Table 62. South Korea Blood Culture Test, by End User USD Million (2013-2018)
  • Table 63. Taiwan Blood Culture Test, by Type USD Million (2013-2018)
  • Table 64. Taiwan Blood Culture Test, by Application USD Million (2013-2018)
  • Table 65. Taiwan Blood Culture Test, by Technology USD Million (2013-2018)
  • Table 66. Taiwan Blood Culture Test, by Technique USD Million (2013-2018)
  • Table 67. Taiwan Blood Culture Test, by End User USD Million (2013-2018)
  • Table 68. Australia Blood Culture Test, by Type USD Million (2013-2018)
  • Table 69. Australia Blood Culture Test, by Application USD Million (2013-2018)
  • Table 70. Australia Blood Culture Test, by Technology USD Million (2013-2018)
  • Table 71. Australia Blood Culture Test, by Technique USD Million (2013-2018)
  • Table 72. Australia Blood Culture Test, by End User USD Million (2013-2018)
  • Table 73. Rest of Asia-Pacific Blood Culture Test, by Type USD Million (2013-2018)
  • Table 74. Rest of Asia-Pacific Blood Culture Test, by Application USD Million (2013-2018)
  • Table 75. Rest of Asia-Pacific Blood Culture Test, by Technology USD Million (2013-2018)
  • Table 76. Rest of Asia-Pacific Blood Culture Test, by Technique USD Million (2013-2018)
  • Table 77. Rest of Asia-Pacific Blood Culture Test, by End User USD Million (2013-2018)
  • Table 78. Europe Blood Culture Test, by Country USD Million (2013-2018)
  • Table 79. Europe Blood Culture Test, by Type USD Million (2013-2018)
  • Table 80. Europe Blood Culture Test, by Application USD Million (2013-2018)
  • Table 81. Europe Blood Culture Test, by Technology USD Million (2013-2018)
  • Table 82. Europe Blood Culture Test, by Technique USD Million (2013-2018)
  • Table 83. Europe Blood Culture Test, by End User USD Million (2013-2018)
  • Table 84. Germany Blood Culture Test, by Type USD Million (2013-2018)
  • Table 85. Germany Blood Culture Test, by Application USD Million (2013-2018)
  • Table 86. Germany Blood Culture Test, by Technology USD Million (2013-2018)
  • Table 87. Germany Blood Culture Test, by Technique USD Million (2013-2018)
  • Table 88. Germany Blood Culture Test, by End User USD Million (2013-2018)
  • Table 89. France Blood Culture Test, by Type USD Million (2013-2018)
  • Table 90. France Blood Culture Test, by Application USD Million (2013-2018)
  • Table 91. France Blood Culture Test, by Technology USD Million (2013-2018)
  • Table 92. France Blood Culture Test, by Technique USD Million (2013-2018)
  • Table 93. France Blood Culture Test, by End User USD Million (2013-2018)
  • Table 94. Italy Blood Culture Test, by Type USD Million (2013-2018)
  • Table 95. Italy Blood Culture Test, by Application USD Million (2013-2018)
  • Table 96. Italy Blood Culture Test, by Technology USD Million (2013-2018)
  • Table 97. Italy Blood Culture Test, by Technique USD Million (2013-2018)
  • Table 98. Italy Blood Culture Test, by End User USD Million (2013-2018)
  • Table 99. United Kingdom Blood Culture Test, by Type USD Million (2013-2018)
  • Table 100. United Kingdom Blood Culture Test, by Application USD Million (2013-2018)
  • Table 101. United Kingdom Blood Culture Test, by Technology USD Million (2013-2018)
  • Table 102. United Kingdom Blood Culture Test, by Technique USD Million (2013-2018)
  • Table 103. United Kingdom Blood Culture Test, by End User USD Million (2013-2018)
  • Table 104. Netherlands Blood Culture Test, by Type USD Million (2013-2018)
  • Table 105. Netherlands Blood Culture Test, by Application USD Million (2013-2018)
  • Table 106. Netherlands Blood Culture Test, by Technology USD Million (2013-2018)
  • Table 107. Netherlands Blood Culture Test, by Technique USD Million (2013-2018)
  • Table 108. Netherlands Blood Culture Test, by End User USD Million (2013-2018)
  • Table 109. Rest of Europe Blood Culture Test, by Type USD Million (2013-2018)
  • Table 110. Rest of Europe Blood Culture Test, by Application USD Million (2013-2018)
  • Table 111. Rest of Europe Blood Culture Test, by Technology USD Million (2013-2018)
  • Table 112. Rest of Europe Blood Culture Test, by Technique USD Million (2013-2018)
  • Table 113. Rest of Europe Blood Culture Test, by End User USD Million (2013-2018)
  • Table 114. MEA Blood Culture Test, by Country USD Million (2013-2018)
  • Table 115. MEA Blood Culture Test, by Type USD Million (2013-2018)
  • Table 116. MEA Blood Culture Test, by Application USD Million (2013-2018)
  • Table 117. MEA Blood Culture Test, by Technology USD Million (2013-2018)
  • Table 118. MEA Blood Culture Test, by Technique USD Million (2013-2018)
  • Table 119. MEA Blood Culture Test, by End User USD Million (2013-2018)
  • Table 120. Middle East Blood Culture Test, by Type USD Million (2013-2018)
  • Table 121. Middle East Blood Culture Test, by Application USD Million (2013-2018)
  • Table 122. Middle East Blood Culture Test, by Technology USD Million (2013-2018)
  • Table 123. Middle East Blood Culture Test, by Technique USD Million (2013-2018)
  • Table 124. Middle East Blood Culture Test, by End User USD Million (2013-2018)
  • Table 125. Africa Blood Culture Test, by Type USD Million (2013-2018)
  • Table 126. Africa Blood Culture Test, by Application USD Million (2013-2018)
  • Table 127. Africa Blood Culture Test, by Technology USD Million (2013-2018)
  • Table 128. Africa Blood Culture Test, by Technique USD Million (2013-2018)
  • Table 129. Africa Blood Culture Test, by End User USD Million (2013-2018)
  • Table 130. North America Blood Culture Test, by Country USD Million (2013-2018)
  • Table 131. North America Blood Culture Test, by Type USD Million (2013-2018)
  • Table 132. North America Blood Culture Test, by Application USD Million (2013-2018)
  • Table 133. North America Blood Culture Test, by Technology USD Million (2013-2018)
  • Table 134. North America Blood Culture Test, by Technique USD Million (2013-2018)
  • Table 135. North America Blood Culture Test, by End User USD Million (2013-2018)
  • Table 136. United States Blood Culture Test, by Type USD Million (2013-2018)
  • Table 137. United States Blood Culture Test, by Application USD Million (2013-2018)
  • Table 138. United States Blood Culture Test, by Technology USD Million (2013-2018)
  • Table 139. United States Blood Culture Test, by Technique USD Million (2013-2018)
  • Table 140. United States Blood Culture Test, by End User USD Million (2013-2018)
  • Table 141. Canada Blood Culture Test, by Type USD Million (2013-2018)
  • Table 142. Canada Blood Culture Test, by Application USD Million (2013-2018)
  • Table 143. Canada Blood Culture Test, by Technology USD Million (2013-2018)
  • Table 144. Canada Blood Culture Test, by Technique USD Million (2013-2018)
  • Table 145. Canada Blood Culture Test, by End User USD Million (2013-2018)
  • Table 146. Mexico Blood Culture Test, by Type USD Million (2013-2018)
  • Table 147. Mexico Blood Culture Test, by Application USD Million (2013-2018)
  • Table 148. Mexico Blood Culture Test, by Technology USD Million (2013-2018)
  • Table 149. Mexico Blood Culture Test, by Technique USD Million (2013-2018)
  • Table 150. Mexico Blood Culture Test, by End User USD Million (2013-2018)
  • Table 151. Company Basic Information, Sales Area and Its Competitors
  • Table 152. Company Basic Information, Sales Area and Its Competitors
  • Table 153. Company Basic Information, Sales Area and Its Competitors
  • Table 154. Company Basic Information, Sales Area and Its Competitors
  • Table 155. Company Basic Information, Sales Area and Its Competitors
  • Table 156. Company Basic Information, Sales Area and Its Competitors
  • Table 157. Company Basic Information, Sales Area and Its Competitors
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Blood Culture Test: by Type(USD Million)
  • Table 162. Blood Culture Test Consumables [Bacterial Infections, Fungal Infections, Mycobacterial Infections, Blood Culture Media, Assay, Kits, and Reagents, Blood Culture Accessories] , by Region USD Million (2019-2024)
  • Table 163. Blood Culture Test Instruments [Bacterial Infections, Fungal Infections, Mycobacterial Infections, Laboratory Equipment, Automated Blood Culture Systems] , by Region USD Million (2019-2024)
  • Table 164. Blood Culture Test Software & Services [Bacterial Infections, Fungal Infections, Mycobacterial Infections] , by Region USD Million (2019-2024)
  • Table 165. Blood Culture Test: by Application(USD Million)
  • Table 166. Blood Culture Test Bacterial Infections , by Region USD Million (2019-2024)
  • Table 167. Blood Culture Test Fungal Infections , by Region USD Million (2019-2024)
  • Table 168. Blood Culture Test Mycobacterial Infections , by Region USD Million (2019-2024)
  • Table 169. Blood Culture Test: by Technique(USD Million)
  • Table 170. Blood Culture Test Conventional , by Region USD Million (2019-2024)
  • Table 171. Blood Culture Test Automated , by Region USD Million (2019-2024)
  • Table 172. Blood Culture Test: by End User(USD Million)
  • Table 173. Blood Culture Test Hospitals Laboratories , by Region USD Million (2019-2024)
  • Table 174. Blood Culture Test Reference Laboratories , by Region USD Million (2019-2024)
  • Table 175. Blood Culture Test Others , by Region USD Million (2019-2024)
  • Table 176. South America Blood Culture Test, by Country USD Million (2019-2024)
  • Table 177. South America Blood Culture Test, by Type USD Million (2019-2024)
  • Table 178. South America Blood Culture Test, by Application USD Million (2019-2024)
  • Table 179. South America Blood Culture Test, by Technology USD Million (2019-2024)
  • Table 180. South America Blood Culture Test, by Technique USD Million (2019-2024)
  • Table 181. South America Blood Culture Test, by End User USD Million (2019-2024)
  • Table 182. Brazil Blood Culture Test, by Type USD Million (2019-2024)
  • Table 183. Brazil Blood Culture Test, by Application USD Million (2019-2024)
  • Table 184. Brazil Blood Culture Test, by Technology USD Million (2019-2024)
  • Table 185. Brazil Blood Culture Test, by Technique USD Million (2019-2024)
  • Table 186. Brazil Blood Culture Test, by End User USD Million (2019-2024)
  • Table 187. Argentina Blood Culture Test, by Type USD Million (2019-2024)
  • Table 188. Argentina Blood Culture Test, by Application USD Million (2019-2024)
  • Table 189. Argentina Blood Culture Test, by Technology USD Million (2019-2024)
  • Table 190. Argentina Blood Culture Test, by Technique USD Million (2019-2024)
  • Table 191. Argentina Blood Culture Test, by End User USD Million (2019-2024)
  • Table 192. Rest of South America Blood Culture Test, by Type USD Million (2019-2024)
  • Table 193. Rest of South America Blood Culture Test, by Application USD Million (2019-2024)
  • Table 194. Rest of South America Blood Culture Test, by Technology USD Million (2019-2024)
  • Table 195. Rest of South America Blood Culture Test, by Technique USD Million (2019-2024)
  • Table 196. Rest of South America Blood Culture Test, by End User USD Million (2019-2024)
  • Table 197. Asia Pacific Blood Culture Test, by Country USD Million (2019-2024)
  • Table 198. Asia Pacific Blood Culture Test, by Type USD Million (2019-2024)
  • Table 199. Asia Pacific Blood Culture Test, by Application USD Million (2019-2024)
  • Table 200. Asia Pacific Blood Culture Test, by Technology USD Million (2019-2024)
  • Table 201. Asia Pacific Blood Culture Test, by Technique USD Million (2019-2024)
  • Table 202. Asia Pacific Blood Culture Test, by End User USD Million (2019-2024)
  • Table 203. China Blood Culture Test, by Type USD Million (2019-2024)
  • Table 204. China Blood Culture Test, by Application USD Million (2019-2024)
  • Table 205. China Blood Culture Test, by Technology USD Million (2019-2024)
  • Table 206. China Blood Culture Test, by Technique USD Million (2019-2024)
  • Table 207. China Blood Culture Test, by End User USD Million (2019-2024)
  • Table 208. Japan Blood Culture Test, by Type USD Million (2019-2024)
  • Table 209. Japan Blood Culture Test, by Application USD Million (2019-2024)
  • Table 210. Japan Blood Culture Test, by Technology USD Million (2019-2024)
  • Table 211. Japan Blood Culture Test, by Technique USD Million (2019-2024)
  • Table 212. Japan Blood Culture Test, by End User USD Million (2019-2024)
  • Table 213. India Blood Culture Test, by Type USD Million (2019-2024)
  • Table 214. India Blood Culture Test, by Application USD Million (2019-2024)
  • Table 215. India Blood Culture Test, by Technology USD Million (2019-2024)
  • Table 216. India Blood Culture Test, by Technique USD Million (2019-2024)
  • Table 217. India Blood Culture Test, by End User USD Million (2019-2024)
  • Table 218. South Korea Blood Culture Test, by Type USD Million (2019-2024)
  • Table 219. South Korea Blood Culture Test, by Application USD Million (2019-2024)
  • Table 220. South Korea Blood Culture Test, by Technology USD Million (2019-2024)
  • Table 221. South Korea Blood Culture Test, by Technique USD Million (2019-2024)
  • Table 222. South Korea Blood Culture Test, by End User USD Million (2019-2024)
  • Table 223. Taiwan Blood Culture Test, by Type USD Million (2019-2024)
  • Table 224. Taiwan Blood Culture Test, by Application USD Million (2019-2024)
  • Table 225. Taiwan Blood Culture Test, by Technology USD Million (2019-2024)
  • Table 226. Taiwan Blood Culture Test, by Technique USD Million (2019-2024)
  • Table 227. Taiwan Blood Culture Test, by End User USD Million (2019-2024)
  • Table 228. Australia Blood Culture Test, by Type USD Million (2019-2024)
  • Table 229. Australia Blood Culture Test, by Application USD Million (2019-2024)
  • Table 230. Australia Blood Culture Test, by Technology USD Million (2019-2024)
  • Table 231. Australia Blood Culture Test, by Technique USD Million (2019-2024)
  • Table 232. Australia Blood Culture Test, by End User USD Million (2019-2024)
  • Table 233. Rest of Asia-Pacific Blood Culture Test, by Type USD Million (2019-2024)
  • Table 234. Rest of Asia-Pacific Blood Culture Test, by Application USD Million (2019-2024)
  • Table 235. Rest of Asia-Pacific Blood Culture Test, by Technology USD Million (2019-2024)
  • Table 236. Rest of Asia-Pacific Blood Culture Test, by Technique USD Million (2019-2024)
  • Table 237. Rest of Asia-Pacific Blood Culture Test, by End User USD Million (2019-2024)
  • Table 238. Europe Blood Culture Test, by Country USD Million (2019-2024)
  • Table 239. Europe Blood Culture Test, by Type USD Million (2019-2024)
  • Table 240. Europe Blood Culture Test, by Application USD Million (2019-2024)
  • Table 241. Europe Blood Culture Test, by Technology USD Million (2019-2024)
  • Table 242. Europe Blood Culture Test, by Technique USD Million (2019-2024)
  • Table 243. Europe Blood Culture Test, by End User USD Million (2019-2024)
  • Table 244. Germany Blood Culture Test, by Type USD Million (2019-2024)
  • Table 245. Germany Blood Culture Test, by Application USD Million (2019-2024)
  • Table 246. Germany Blood Culture Test, by Technology USD Million (2019-2024)
  • Table 247. Germany Blood Culture Test, by Technique USD Million (2019-2024)
  • Table 248. Germany Blood Culture Test, by End User USD Million (2019-2024)
  • Table 249. France Blood Culture Test, by Type USD Million (2019-2024)
  • Table 250. France Blood Culture Test, by Application USD Million (2019-2024)
  • Table 251. France Blood Culture Test, by Technology USD Million (2019-2024)
  • Table 252. France Blood Culture Test, by Technique USD Million (2019-2024)
  • Table 253. France Blood Culture Test, by End User USD Million (2019-2024)
  • Table 254. Italy Blood Culture Test, by Type USD Million (2019-2024)
  • Table 255. Italy Blood Culture Test, by Application USD Million (2019-2024)
  • Table 256. Italy Blood Culture Test, by Technology USD Million (2019-2024)
  • Table 257. Italy Blood Culture Test, by Technique USD Million (2019-2024)
  • Table 258. Italy Blood Culture Test, by End User USD Million (2019-2024)
  • Table 259. United Kingdom Blood Culture Test, by Type USD Million (2019-2024)
  • Table 260. United Kingdom Blood Culture Test, by Application USD Million (2019-2024)
  • Table 261. United Kingdom Blood Culture Test, by Technology USD Million (2019-2024)
  • Table 262. United Kingdom Blood Culture Test, by Technique USD Million (2019-2024)
  • Table 263. United Kingdom Blood Culture Test, by End User USD Million (2019-2024)
  • Table 264. Netherlands Blood Culture Test, by Type USD Million (2019-2024)
  • Table 265. Netherlands Blood Culture Test, by Application USD Million (2019-2024)
  • Table 266. Netherlands Blood Culture Test, by Technology USD Million (2019-2024)
  • Table 267. Netherlands Blood Culture Test, by Technique USD Million (2019-2024)
  • Table 268. Netherlands Blood Culture Test, by End User USD Million (2019-2024)
  • Table 269. Rest of Europe Blood Culture Test, by Type USD Million (2019-2024)
  • Table 270. Rest of Europe Blood Culture Test, by Application USD Million (2019-2024)
  • Table 271. Rest of Europe Blood Culture Test, by Technology USD Million (2019-2024)
  • Table 272. Rest of Europe Blood Culture Test, by Technique USD Million (2019-2024)
  • Table 273. Rest of Europe Blood Culture Test, by End User USD Million (2019-2024)
  • Table 274. MEA Blood Culture Test, by Country USD Million (2019-2024)
  • Table 275. MEA Blood Culture Test, by Type USD Million (2019-2024)
  • Table 276. MEA Blood Culture Test, by Application USD Million (2019-2024)
  • Table 277. MEA Blood Culture Test, by Technology USD Million (2019-2024)
  • Table 278. MEA Blood Culture Test, by Technique USD Million (2019-2024)
  • Table 279. MEA Blood Culture Test, by End User USD Million (2019-2024)
  • Table 280. Middle East Blood Culture Test, by Type USD Million (2019-2024)
  • Table 281. Middle East Blood Culture Test, by Application USD Million (2019-2024)
  • Table 282. Middle East Blood Culture Test, by Technology USD Million (2019-2024)
  • Table 283. Middle East Blood Culture Test, by Technique USD Million (2019-2024)
  • Table 284. Middle East Blood Culture Test, by End User USD Million (2019-2024)
  • Table 285. Africa Blood Culture Test, by Type USD Million (2019-2024)
  • Table 286. Africa Blood Culture Test, by Application USD Million (2019-2024)
  • Table 287. Africa Blood Culture Test, by Technology USD Million (2019-2024)
  • Table 288. Africa Blood Culture Test, by Technique USD Million (2019-2024)
  • Table 289. Africa Blood Culture Test, by End User USD Million (2019-2024)
  • Table 290. North America Blood Culture Test, by Country USD Million (2019-2024)
  • Table 291. North America Blood Culture Test, by Type USD Million (2019-2024)
  • Table 292. North America Blood Culture Test, by Application USD Million (2019-2024)
  • Table 293. North America Blood Culture Test, by Technology USD Million (2019-2024)
  • Table 294. North America Blood Culture Test, by Technique USD Million (2019-2024)
  • Table 295. North America Blood Culture Test, by End User USD Million (2019-2024)
  • Table 296. United States Blood Culture Test, by Type USD Million (2019-2024)
  • Table 297. United States Blood Culture Test, by Application USD Million (2019-2024)
  • Table 298. United States Blood Culture Test, by Technology USD Million (2019-2024)
  • Table 299. United States Blood Culture Test, by Technique USD Million (2019-2024)
  • Table 300. United States Blood Culture Test, by End User USD Million (2019-2024)
  • Table 301. Canada Blood Culture Test, by Type USD Million (2019-2024)
  • Table 302. Canada Blood Culture Test, by Application USD Million (2019-2024)
  • Table 303. Canada Blood Culture Test, by Technology USD Million (2019-2024)
  • Table 304. Canada Blood Culture Test, by Technique USD Million (2019-2024)
  • Table 305. Canada Blood Culture Test, by End User USD Million (2019-2024)
  • Table 306. Mexico Blood Culture Test, by Type USD Million (2019-2024)
  • Table 307. Mexico Blood Culture Test, by Application USD Million (2019-2024)
  • Table 308. Mexico Blood Culture Test, by Technology USD Million (2019-2024)
  • Table 309. Mexico Blood Culture Test, by Technique USD Million (2019-2024)
  • Table 310. Mexico Blood Culture Test, by End User USD Million (2019-2024)
  • Table 311. Research Programs/Design for This Report
  • Table 312. Key Data Information from Secondary Sources
  • Table 313. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Blood Culture Test: by Type USD Million (2013-2018)
  • Figure 5. Global Blood Culture Test: by Application USD Million (2013-2018)
  • Figure 6. Global Blood Culture Test: by Technique USD Million (2013-2018)
  • Figure 7. Global Blood Culture Test: by End User USD Million (2013-2018)
  • Figure 8. South America Blood Culture Test Share (%), by Country
  • Figure 9. Asia Pacific Blood Culture Test Share (%), by Country
  • Figure 10. Europe Blood Culture Test Share (%), by Country
  • Figure 11. MEA Blood Culture Test Share (%), by Country
  • Figure 12. North America Blood Culture Test Share (%), by Country
  • Figure 13. Global Blood Culture Test share by Players 2018 (%)
  • Figure 14. Global Blood Culture Test share by Players (Top 3) 2018(%)
  • Figure 15. Global Blood Culture Test share by Players (Top 5) 2018(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 18. Becton, Dickinson and Company (United States) Revenue: by Geography 2018
  • Figure 19. BioMérieux SA (France) Revenue, Net Income and Gross profit
  • Figure 20. BioMérieux SA (France) Revenue: by Geography 2018
  • Figure 21. Thermo Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Thermo Fisher Scientific, Inc. (United States) Revenue: by Geography 2018
  • Figure 23. Cepheid, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Cepheid, Inc. (United States) Revenue: by Geography 2018
  • Figure 25. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 26. Abbott Laboratories (United States) Revenue: by Geography 2018
  • Figure 27. Nanosphere, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Nanosphere, Inc. (United States) Revenue: by Geography 2018
  • Figure 29. Roche Diagnostics (Switzerland) Revenue, Net Income and Gross profit
  • Figure 30. Roche Diagnostics (Switzerland) Revenue: by Geography 2018
  • Figure 31. Beckman Coulter (United States) Revenue, Net Income and Gross profit
  • Figure 32. Beckman Coulter (United States) Revenue: by Geography 2018
  • Figure 33. Bruker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 34. Bruker Corporation (United States) Revenue: by Geography 2018
  • Figure 35. IRIDICA (United States) Revenue, Net Income and Gross profit
  • Figure 36. IRIDICA (United States) Revenue: by Geography 2018
  • Figure 37. Global Blood Culture Test: by Type USD Million (2019-2024)
  • Figure 38. Global Blood Culture Test: by Application USD Million (2019-2024)
  • Figure 39. Global Blood Culture Test: by Technique USD Million (2019-2024)
  • Figure 40. Global Blood Culture Test: by End User USD Million (2019-2024)
  • Figure 41. South America Blood Culture Test Share (%), by Country
  • Figure 42. Asia Pacific Blood Culture Test Share (%), by Country
  • Figure 43. Europe Blood Culture Test Share (%), by Country
  • Figure 44. MEA Blood Culture Test Share (%), by Country
  • Figure 45. North America Blood Culture Test Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Becton, Dickinson and Company (United States)
  • bioMérieux SA (France)
  • Thermo Fisher Scientific, Inc. (United States)
  • Cepheid, Inc. (United States)
  • Abbott Laboratories (United States)
  • Nanosphere, Inc. (United States)
  • Roche Diagnostics (Switzerland)
  • Beckman Coulter (United States)
  • Bruker Corporation (United States)
  • IRIDICA (United States)
Additional players considered in the study are as follows:
T2 Biosystems (United States) , Danaher Corporation (United States) , Luminex Corporation (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount
Slider
Slider
Slider
DOWNLOAD SAMPLE PDF

Speak with Analyst

Want to find out more about this report?

Get Free Consultation
Ask a Question!

Related Reports

Renal Biomarker Comprehensive Study by Type (Diagnostic Biomarkers, Prognostic Biomarkers, Predictive Biomarkers, Pharmacodynamic Biomarkers), Application (Hospital, Diagnostic Laboratory, Other), Di...
Renal Biomarker Comprehensive Study by Type (Diagnostic Biomarkers, Prognostic Biomarkers, Predictive Biomarkers, Pharmacodynamic Biomarkers), Application (Hospital, Diagnostic Laboratory, Other), Di...
$ 3800
Molecular Diagnostic Comprehensive Study by Type (Instruments, Reagents, Others), Application (Infectious Disease, Blood Screening, Genetic Testing, Oncology Testing), Technology (PCR, In Situ Hybrid...
Molecular Diagnostic Comprehensive Study by Type (Instruments, Reagents, Others), Application (Infectious Disease, Blood Screening, Genetic Testing, Oncology Testing), Technology (PCR, In Situ Hybrid...
$ 3800
Sciatica Treatment Comprehensive Study by Type (L4 Nerve Root Sciatica, L5 Nerve Root Sciatica, S1 Nerve Root Sciatica, Others), Drugs (Anesthetics, Pain killers, Muscle relaxants, Antidepressants, S...
Sciatica Treatment Comprehensive Study by Type (L4 Nerve Root Sciatica, L5 Nerve Root Sciatica, S1 Nerve Root Sciatica, Others), Drugs (Anesthetics, Pain killers, Muscle relaxants, Antidepressants, S...
$ 3800
Rhytidectomy Comprehensive Study by Type (Drugs (Antiscarring, Dressings and Compression Support, Sealant), Sutures, Others), Application (Hospitals, Clinics), Type (Full Facelift, Mid Facelift (Uppe...
Rhytidectomy Comprehensive Study by Type (Drugs (Antiscarring, Dressings and Compression Support, Sealant), Sutures, Others), Application (Hospitals, Clinics), Type (Full Facelift, Mid Facelift (Uppe...
$ 3800
Fenofibric Acid Comprehensive Study by Type (45 mg Delayed Release Capsules, 135 mg Delayed Release Capsules), Application (Hospital, Drug store) Players and Region - Global Market Outlook to 2024
Fenofibric Acid Comprehensive Study by Type (45 mg Delayed Release Capsules, 135 mg Delayed Release Capsules), Application (Hospital, Drug store) Players and Region - Global Market Outlook to 2024
$ 3800
Molecular Diagnostics Comprehensive Study by Type (Instruments, Reagents, Software & Services), Application (Infectious Diseases (HIV, HPV, Tuberculosis and Other Infectious Diseases), Oncology (Brea...
Molecular Diagnostics Comprehensive Study by Type (Instruments, Reagents, Software & Services), Application (Infectious Diseases (HIV, HPV, Tuberculosis and Other Infectious Diseases), Oncology (Brea...
$ 3800